Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Not Confirmed
Not Confirmed
08-10 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Not Confirmed
08-10 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
28 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-28/puretech-health-plc-half-year-report
21 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250821614975/en/PureTech-Showcases-Differentiated-Development-Strategy-Including-New-Patient-Preference-Insights-and-Spotlights-Phase-2b-Data-Positioning-Deupirfenidone-as-a-Potential-New-Standard-of-Care-in-IPF
18 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250817840693/en/PureTech-Health-Notice-of-Half-Yearly-Results
13 Aug 2025
// FIERCE PHARMA
https://www.fiercebiotech.com/biotech/puretech-launches-celea-therapeutics-develop-highly-touted-lung-disease-candidate
17 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250717210406/en/PureTech-Founded-Entity-Seaport-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2b-BUOY-1-Study-of-GlyphAllo-SPT-300-in-Major-Depressive-Disorder-MDD-With-or-Without-Anxious-Distress
08 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250708508613/en/PureTech-Announces-Board-Change
ABOUT THIS PAGE